Project Oncology®
Showcasing major breakthroughs in cancer care from worldwide clinical trials, Project Oncology® educates and assists the healthcare professionals who dedicate their lives to helping patients fight cancer.
Here you’ll find leading oncologists discuss and share essential cancer care strategies for all different types of cancer. And as worldwide clinical trials continue to explore new screening tests and discover novel treatment options, you can rest assured that you’ll always catch the latest in cancer research with Project Oncology®.
Examining a Therapeutic Modality for 2L+ mNSCLC
Medical Industry FeatureExamining a Therapeutic Modality for 2L+ mNSCLC
The CLL Patient Journey: From Diagnosis to Initial Treatment
Medical Industry FeatureThe CLL Patient Journey: From Diagnosis to Initial Treatment
Navigating CLL Treatment: Patient Preferences and Shared Decision-Making
Medical Industry FeatureNavigating CLL Treatment: Patient Preferences and Shared Decision-Making
Clinical Insights into Higher-Risk MDS: Treatment Goals and Strategies
Medical Industry FeatureClinical Insights into Higher-Risk MDS: Treatment Goals and Strategies
EMERALD Expert Views: Managing ER+/HER2-, ESR1m mBC Disease Progression Post ET+CDK4/6i
Medical Industry FeatureEMERALD Expert Views: Managing ER+/HER2-, ESR1m mBC Disease Progression Post ET+CDK4/6i
Considerations for Time-limited Treatment in 1L Treatment Selection Decisions
Medical Industry FeatureConsiderations for Time-limited Treatment in 1L Treatment Selection Decisions
An Analysis of Subcutaneous Versus Intravenous Atezolizumab in NSCLC
Spotlight On Subcutaneous Cancer ImmunotherapiesAn Analysis of Subcutaneous Versus Intravenous Atezolizumab in NSCLC
Unresectable Hepatocellular Carcinoma Care: Investigating a Combination Therapy
Project Oncology®Unresectable Hepatocellular Carcinoma Care: Investigating a Combination Therapy
AML Care: Examining the Efficacy and Safety of a Triplet Combination Therapy
Project Oncology®AML Care: Examining the Efficacy and Safety of a Triplet Combination Therapy
Nanrilkefusp Alfa: A Promising Subcutaneous IL-15Rβγ Superagonist
Spotlight On Subcutaneous Cancer ImmunotherapiesNanrilkefusp Alfa: A Promising Subcutaneous IL-15Rβγ Superagonist
Evaluating Alemtuzumab in Adult ALL: Insights from a Phase 1/2 Clinical Trial
Spotlight On Subcutaneous Cancer ImmunotherapiesEvaluating Alemtuzumab in Adult ALL: Insights from a Phase 1/2 Clinical Trial
Advancing Multiple Myeloma Treatment: The Role of Immunotherapy and Personalized Care
Project Oncology®Advancing Multiple Myeloma Treatment: The Role of Immunotherapy and Personalized Care
Reviewing the Latest Bladder Cancer Practice Guidelines
MinuteCE®Reviewing the Latest Bladder Cancer Practice Guidelines
Exploring New and Emerging Treatments in Muscle Invasive Bladder Cancer
MinuteCE®Exploring New and Emerging Treatments in Muscle Invasive Bladder Cancer
- 03/21/2025
- 03/20/2025
- 03/20/2025
- 03/19/2025
- 03/19/2025
- 03/19/2025